Tower Research Capital (TRC)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Buy |
|
|||||
|
2025
Q1 | $227K | Buy |
|
|||||
|
2024
Q4 | $95K | Buy |
|
|||||
|
2024
Q3 | $130K | Sell |
|
|||||
|
2024
Q2 | $939K | Buy |
|
|||||
|
2024
Q1 | $27.7K | Sell |
|
|||||
|
2023
Q4 | $112K | Buy |
|
|||||
|
2023
Q3 | $115K | Buy |
|
|||||
|
2023
Q2 | $127K | Sell |
|
|||||
|
2023
Q1 | $216K | Buy |
|
|||||
|
2022
Q4 | $115K | Sell |
|
|||||
|
2022
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q2 | $726K | Buy |
|
|||||
|
2022
Q1 | $126K | Sell |
|
|||||
|
2021
Q4 | $592K | Buy |
|
|||||
|
2021
Q3 | $355K | Sell |
|
|||||
|
2021
Q2 | $453K | Sell |
|
|||||
|
2021
Q1 | $3.79M | Buy |
|
|||||
|
2020
Q4 | $32K | Sell |
|
|||||
|
2020
Q3 | $120K | Buy |
|
|||||
|
2020
Q2 | $76K | Buy |
|
|||||
|
2020
Q1 | $0 | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $19K | Sell |
|
|||||
|
2019
Q2 | $149K | Buy |
|
|||||
|
2019
Q1 | $2K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $70K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $40K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $70K | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $27K | Sell |
|
|||||
|
2016
Q3 | $69K | Buy |
|
|||||
|
2016
Q2 | $14K | Buy |
|